Why the study?
Does esmolol combined with ibutilide improve conversion to sinus rhythm in patients with rapidly conducting atrial fibrillation?
Population
90 patients with rapidly conducting atrial fibrillation, mean age 63 +/- 13.5 years.
Comparison
Esmolol titrated to achieve a heart rate of <100… vs Ibutilide monotherapy
Design
RCT, Randomized in to two groups
Follow-up
Acute (at the time of conversion)
Authors
Loading...
Supports esmolol addition to ibutilide for cardioversion in rapid AF; confirms adjunctive benefit in this RCT.
Does esmolol combined with ibutilide improve conversion to sinus rhythm in patients with rapidly conducting atrial fibrillation?
The addition of esmolol to ibutilide improves the efficacy of cardioversion to sinus rhythm in patients with rapidly conducting atrial fibrillation while reducing QTc prolongation and VT risk, though with increased bradycardia.
Fragakis et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: